The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Brain imaging of18F‐fallypride in normal volunteers: Blood analysis, distribution, test‐retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D‐2/D‐3 receptors
Abstract
Human studies of dopamine D2/D3 receptors using 18 F‐fallypride‐PET in normal volunteers were performed to evaluate brain distribution in striatal and extrastriatal regions, evaluate metabolites in blood plasma, establish PET imaging protocol for this new radiotracer, evaluate graphical methods of analysis to quantitate D2/D3 receptors, and assess the ability of 18 F‐fallypride to measure changes in D2/D3 receptors with aging as a model. Subjects (6; 21–63 years) had a PET scan on a Siemens HR+ scanner with 18 F‐fallypride and a T1‐weighted MRI scan on a 1.5T GE scanner for purposes of anatomical coregistration with PET. A 3‐h PET scan with 18 F‐fallypride (0.07 mCi/Kg) was carried out on each subject and repeated in 4–6 weeks. Arterial or arterialized venous blood was obtained in all subjects in order to evaluate blood activity levels and analyze metabolites in the plasma. Brain regions‐of‐interest were identified and drawn using PET and PET‐MR coregistered images. PET data was analyzed using graphical methods in which cerebellum was used as the reference region providing distribution volume ratios (DVR) from which binding potential (BP) was derived and used as a measure of concentration of receptors. Distribution of 18 F‐fallypride was consistent in all subjects studied and the rank order of receptor concentration was putamen > caudate > thalamus = pituitary > amygdala > colliculi > substantia nigra > hippocampus = temporal cortex > parietal cortex = occipital cortex = orbitofrontal cortex. For younger subjects, BP ranged from 37 for the putamen to 0.4 for orbitofrontal cortex, with a test–retest error of about 10%. Both hydrophilic and lipophilic metabolites were observed in arterial blood plasma and analyses showed approx. 30–40% of plasma radioactivity at 3 h was 18 F‐fallypride. With aging, all brain regions exhibited a significant decrease (>10% per decade) in binding of 18 F‐fallypride. PET studies with 18 F‐fallypride are thus suitable to study changes in D2/D3 receptors in striatal and extrastriatal brain regions. Synapse 46:170–188, 2002. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070
Rapid Automated Algorithm for Aligning and Reslicing PET Images
Woods, R. P., Cherry, S. R., & Mazziotta, J. C. (1992) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199207000-00024 · Cited by 1,912
Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data
Logan, J., Fowler, J. S., Volkow, N. D., Wang, G.-J., Ding, Y.-S., & Alexoff, D. L. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199609000-00008 · Cited by 1,514
Jeurgen, K., Assheuer, J., & Paxinos, G. (1997) · Medical Entomology and Zoology · Cited by 1,403
Mintun, M. A., Raichle, M. E., Kilbourn, M. R., Wooten, G. F., & Welch, M. J. (1984) · Annals of Neurology · doi:10.1002/ana.410150302 · Cited by 955
Volkow, N. D., Wang, G.-J., Fowler, J. S., Gatley, S. J., Logan, J., Ding, Y.-S., Hitzemann, R., & Pappas, N. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.10.1325 · Cited by 885
Comparison and Evaluation of Retrospective Intermodality Brain Image Registration Techniques
West, J., Fitzpatrick, J. M., Wang, M. Y., Dawant, B. M., Maurer, C. R., Kessler, R. M., Maciunas, R. J., Barillot, C., Lemoine, D., Collignon, A., et al. (1997) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199707000-00007 · Cited by 884
(1998) · PubMed · doi:10.1176/ajp.155.3.344 · Cited by 784
Do Novel Antipsychotics Have Similar Pharmacological Characteristics? A Review of the Evidence
Arnt, J. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00112-7 · Cited by 715
Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria
Drevets, W. C., Gautier, C., Price, J. C., Kupfer, D. J., Kinahan, P. E., Grace, A. A., Price, J. L., & Mathis, C. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01038-6 · Cited by 706
Brix, G., Zaers, J., Adam, L.-E., Bellemann, M. E., Ostertag, H. J., Trojan, H., Haberkorn, U., Doll, J., Oberdorfer, F., & Lorenz, W. J. (1997) · PubMed · Cited by 479
Dopamine Agonists and Pituitary Tumor Shrinkage
BEVAN, J. S., WEBSTER, J., Burke, C. W., & Scanlon, M. F. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-2-220 · Cited by 469
Farde, L., Eriksson, L., Blomquist, G., & Halldin, C. (1989) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1989.98 · Cited by 448
Principles of Neuropsychopharmacology
Feldman, R. S., Meyer, J. S., & Quenzer, L. F. (1997) · Cited by 444
Gurevich, E. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00066-9 · Cited by 431
Distribution of D1- and D2-Dopamine Receptors, and Dopamine and Its Metabolites in the Human Brain
Hall, H., Sedvall, G., Magnusson, O., Kopp, J., Halldin, C., & Farde, L. (1994) · Neuropsychopharmacology · doi:10.1038/sj.npp.1380111 · Cited by 419
Graphical analysis of PET data applied to reversible and irreversible tracers
Logan, J. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00137-2 · Cited by 416
Bouthenet, M.-L., Martres, M.-P., Sales, N., & Schwartz, J.-C. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90008-x · Cited by 356
Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain
Kaasinen, V (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00149-4 · Cited by 352
Schizophrenia: A Subcortical Neurotransmitter Imbalance Syndrome?
Carlsson, M., & Carlsson, A. (1990) · Schizophrenia Bulletin · doi:10.1093/schbul/16.3.425 · Cited by 341
SEEMAN, P. (1987) · Neuropsychopharmacology · doi:10.1016/0893-133x(87)90004-2 · Cited by 316
Khan, Z. U., Guti�rrez, A., Mart�n, R., Pe�afiel, A., Rivera, A., & De La Calle, A. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19981221)402:3<353::aid-cne5>3.0.co;2-4 · Cited by 271
Sex Differences in the Striatal Dopamine D2 Receptor Binding Characteristics in Vivo
Pohjalainen, T., Rinne, J. O., Någren, K., SyvÄlahti, E., & Hietala, J. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.6.768 · Cited by 247
Amygdala Regulation of Nucleus Accumbens Dopamine Output is Governed by the Prefrontal Cortex
Jackson, M. E., & Moghaddam, B. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00676.2001 · Cited by 246
Mukherjee, J., Yang, Z.-Y., Das, M. K., & Brown, T. (1995) · Nuclear Medicine and Biology · doi:10.1016/0969-8051(94)00117-3 · Cited by 219
Self-citationLidow, M. S., Goldman-Rakic, P. S., Rakic, P., & Innis, R. B. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6412 · Cited by 209
Dopamine D2 Receptors in the Insular Cortex and the Personality Trait of Novelty Seeking
Suhara, T., Yasuno, F., Sudo, Y., Yamamoto, M., Inoue, M., Okubo, Y., & Suzuki, K. (2001) · NeuroImage · doi:10.1006/nimg.2001.0761 · Cited by 184
Reproducibility of repeated measures of carbon-11-raclopride binding in the human brain.
Volkow, N. D., Fowler, J. S., Wang, G., Dewey, S. L., Schlyer, D. J., MacGregor, R. R., Logan, J., Alexoff, D. L., Shea, C. E., & HITZEMANN, R. J. (1993) · PubMed · Cited by 178
Farde, L., Suhara, T., Karlsson, P., Hietala, J., Nakashima, Y., Halldin, C., & Nyberg, S. (1997) · Psychopharmacology · doi:10.1007/s002130050420 · Cited by 177
Psychostimulant sensitization: differential changes in accumbal shell and core dopamine
Cadoni, C., Solinas, M., & Di Chiara, G. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00824-9 · Cited by 172
Kessler, R. M., Whetsell, W. O., Sib Ansari, M., Votaw, J. R., de Paulis, T., Clanton, J. A., Schmidt, D. E., Scott Mason, N., & Manning, R. G. (1993) · Brain Research · doi:10.1016/0006-8993(93)90878-q · Cited by 159
Sex Differences in Extrastriatal Dopamine D2-Like Receptors in the Human Brain
Kaasinen, V., Någren, K., Hietala, J. A., Farde, L., & Rinne, J. O. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.308 · Cited by 151
Melchitzky, D. S., & Lewis, D. A. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00139-6 · Cited by 149
Joyce, J. N., Loeschen, S. K., & Marshall, J. F. (1985) · Brain Research · doi:10.1016/0006-8993(85)90149-0 · Cited by 147
In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans.
Kung, H. F., Alavi, A. A., Chang, W., Kung, M., Keyes, J. W., VELCHIK, M. G., Billings, J. J., Pan, S., Noto, R. B., & Rausch, A. (1990) · PubMed · Cited by 137
Mukherjee, J., Yang, Z.-Y., Brown, T., Lew, R., Wernick, M. N., Ouyang, X., Yasillo, N. J., Chen, C.-T., Mintzer, R. A., & Cooper, M. (1999) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(99)00012-8 · Cited by 131
Self-citationHall, H., Halldin, C., Dijkstra, D., Wikström, H., Wise, L. D., Pugsley, T. A., Sokoloff, P., Pauli, S., Farde, L., & Sedvall, G. (1996) · Psychopharmacology · doi:10.1007/s002130050131 · Cited by 128
Gender-specific aging effects on the serotonin 1A receptor
MELTZER, C. C., Drevets, W. C., Price, J. C., Mathis, C. A., Lopresti, B. J., Greer, P. J., Villemagne, V. L., Holt, D. P., Mason, N. S., Houck, P. R., et al. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03211-x · Cited by 107
Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2
Niznik, H. B., Grigoriadis, D. E., Pri‐Bar, I., Buchman, O., & Seeman, P. M. (1985) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00496365 · Cited by 106
Volume image registration by template matching
Ding, L., Ardeshir Goshtasby, A., & Satter, M. (2001) · Image and Vision Computing · doi:10.1016/s0262-8856(00)00101-3 · Cited by 96
Self-citationLeft-right asymmetry of striatal dopamine D2 receptors
Larisch, R., MEYER, W., Klimke, A., Kehren, F., Vosberg, H., & Müller-Gärtner, H.-W. (1998) · Nuclear Medicine Communications · doi:10.1097/00006231-199808000-00009 · Cited by 83
Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorders
Verhoeff, N. P. L. G. (1999) · Psychopharmacology · doi:10.1007/s002130051163 · Cited by 78
Christian, B. T., Narayanan, T. K., Shi, B., & Mukherjee, J. (2000) · Synapse · doi:10.1002/1098-2396(200010)38:1<71::aid-syn8>3.0.co;2-2 · Cited by 76
Self-citationDopamine receptors and transporters : pharmacology, structure, and function
Niznik, H. B. (1994) · Cited by 73
Disrupted Pattern of D2 Dopamine Receptors in the Temporal Lobe in Schizophrenia
Goldsmith, S. K. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190077008 · Cited by 71
Semsei, I. (2000) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(00)00147-0 · Cited by 68
Janowsky, A. J., Neve, K. A., Kinzie, J. M., Taylor, B., de Paulis, T., & Belknap, J. K. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11150-6 · Cited by 68
Age-related changes in D2 receptor binding with iodine-123-iodobenzofuran SPECT.
Ichise, M., Ballinger, J. R., Tanaka, F., Moscovitch, M., George‐Hyslop, P. S., Raphael, D., & Freedman, M. (1998) · PubMed · Cited by 66
Okubo, Y., Olsson, H., Ito, H., Lofti, M., Suhara, T., Halldin, C., & Farde, L. (1999) · NeuroImage · doi:10.1006/nimg.1999.0502 · Cited by 64
Dopamine D2 receptors in the hippocampus and amygdala in Alzheimer's disease
Joyce, J. N., Kaeger, C., Ryoo, H., & Goldsmith, S. K. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90199-u · Cited by 55
Dopamine D2 receptors are organized in bands in normal human temporal cortex
Goldsmith, S. K., & Joyce, J. N. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00132-7 · Cited by 50
Dopamine D2 receptor bands in normal human temporal cortex are absent in Alzheimer's disease
Joyce, J. N., Myers, A., & Gurevich, E. V. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01005-6 · Cited by 47
Disposition of remoxipride in different species. Species differences in metabolism.
Widman, M., Nilsson, L., Bryske, B., & Lundström, J. (1993) · PubMed · Cited by 46
Ito, H., Sudo, Y., Suhara, T., et al. (2001) · NeuroImage · doi:10.1006/nimg.2000.0717 · Cited by 44
Boulenguez, P., Pinard, R., & Ségu, L. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199611)24:3<224::aid-syn4>3.0.co;2-g · Cited by 32
Loc’h, C., Halldin, C., Bottlaender, M., Swahn, C.-G., Moresco, R.-M., Mazière, M., Farde, L., & Maziere, B. (1996) · Nuclear Medicine and Biology · doi:10.1016/0969-8051(96)00078-9 · Cited by 31
Mathieu-Kia, A.-M., Caboche, J., & Besson, M. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199606)23:2<115::aid-syn7>3.0.co;2-c · Cited by 27
Self-regulation of slow cortical potentials: an event-related fMRI study
Veit, R., Strehl, U., Hinterberger, T., Erb, M., Grodd, W., & Birbaumer, N. (2000) · NeuroImage · doi:10.1016/s1053-8119(00)90966-2 · Cited by 11
Tohgi, H., Utsugisawa, K., Yoshimura, M., Nagane, Y., & Mihara, M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00080-9 · Cited by 6
Cited by
Ruffman, T., Henry, J. D., Livingstone, V., & Phillips, L. H. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.01.001 · Cited by 917
Peters, R. (2006) · Postgraduate Medical Journal · doi:10.1136/pgmj.2005.036665 · Cited by 894
Synthesis of 11C, 18F, 15O, and 13N Radiolabels for Positron Emission Tomography
Miller, P. W., Long, N. J., Vilar, R., & Gee, A. D. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200800222 · Cited by 894
Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease
Trist, B. G., Hare, D. J., & Double, K. L. (2019) · Aging Cell · doi:10.1111/acel.13031 · Cited by 778
PET radiotracers: crossing the blood–brain barrier and surviving metabolism
Pike, V. W. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.05.005 · Cited by 582
Metadata
- Authors
- Mukherjee, J., Christian, B. T., Dunigan, K. A., Shi, B., Narayanan, T. K., Satter, M., & Mantil, J.
- Venue
- Synapse
- Publisher
- Wiley
- Published
- 2002-09-05
- Volume
- 46
- Issue
- 3
- Pages
- 170-188
- ISSN
- 0887-4476 (ISSN-L)
- 1098-2396
- OpenAlex
- W2079598508
- Cited by
- 270
- References
- 59
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.